Genetic characterization of ESBL-producing strains of Klebsiella pneumoniae from Tehran hospitals

Journal of Infection in Developing Countries

Volumn 4, Issue 10, 2010, Pages 609-615

  Feizabadi, Mohammad Mehdi ^a   Mohammadi Yeganeh, Samira ^a   Mirsalehian, Akbar ^a   Azimi, Poorya ^a   Mirafshar, Seyed Mohammad ^a   Mahboobi, Mohaddeseh ^b   Nili, Firoozeh ^a   Yadegarinia, Davood ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Barij Essence Pharmaceutical Industry ^*  (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ESBL; FIGE; Iran; Klebsiella pneumoniae; PCR; PFGE

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ARTICLE; BACTERIUM IDENTIFICATION; CLASSIFICATION; CLUSTER ANALYSIS; CROSS INFECTION; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HOSPITAL; HUMAN; IRAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CARBAPENEMS; CLUSTER ANALYSIS; CROSS INFECTION; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HOSPITALS; HUMANS; IRAN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 79957754204     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1059     Document Type: Article

References (26)

1. Bush K (2008) Extended-spectrum beta-lactamases in North America. 1987-2006. Clin Microbiol Infect 14:134-143.
2. Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13(47).
3. Gur D, Hascelik G, Aydin N, Telli M, Gültekin M, Ogülnç D, Arikan OA, Uysal S, Yaman A, Kibar F, Gülay Z, Sumerkan B, Esel D, Kayacan CB, Aktas Z, Soyletir G, Altinkanat G, Durupinar B, Darka O, Akgün Y, Yayla B, Gedikoglu S, Sinirtas M, Berktas M, Yaman G. (2009) Antimicrobial resistance in gram-negative hospital isolates: results of the Turkish HITIT-2 Surveillance Study of 2007. J Chemother 21: 383-389.
4. Hawkey PM (2008) Prevalence and clonality of extended- spectrum beta-lactamases in Asia. Clin Microbiol Infect 14: 159-165.
5. Shahcheraghi F, Moezi H, Feizabadi MM (2007) Distribution of TEM and SHV Beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit 13:247-250.
6. Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, Parvin M, Yadegarinia D (2009) Distribution of bla(TEM), bla(SHV), bla(CTX-M) Genes Among Clinical Isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microb Drug Resist 16: 49-53.
7. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S (2006) Antibiotic-resistance patterns and frequency of extended-spectrum beta- lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit 12: 362-365.
8. Bouallegue-Godet O, Grimont F, Ben Salem Y, Saidani M, Mzoughi R, Sboui H, Grimont PA (2005) Investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases in a neonatal ward, Sousse, Tunisia. Pathol Biol 53:75-80.
9. Mesko Meglic K, Koren S, Palepou MF, Karisik E, Livermore DM, Pike R, Andlovic A, Jeverica S, Krizan- Hergouth V, Müller-Premru M, Seme K; Slovenian ESBL Study Group, Woodford N.(2009) Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals. Antimicrob Agents Chemother 53:287-291.
10. JF MacFaddin (1999) Biochemical tests for identification of medical bacteria. Philadelphia: Lippincott Williams and Wilkinson. CLSI Performance StandardsforAntimicrobial Susceptibility Testing (2006) Vol.Informational Supplement, 16th edn M100-S16.
11. Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, Kang MW (2005) Prevalence of Ambler class A and D beta- lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother 56: 122-127.
12. Wofford D, Olsen G, Waddel I (1996) Molecular Systemics. Massachusetts: Sinauer Associates Inc. Sunderland, USA.
13. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomalDNArestriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
14. Perez F, Endimiani A, Hujer KM, Bonomo RA (2007) The continuing challenge of ESBLs. Curr Opin Pharmacol 7: 459-469.
15. Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D (2008) Prevalence and antimicrobial susceptibility pattern of extended-spectrumbeta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract 17: 32-36.
16. Mokaddas EM, Abdulla AA, Shati S, Rotimi VO (2008) The technical aspects and clinical significance of detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait. J Chemother 20: 445-451.
17. Khanfar HS, Bindayna KM, Senok AC, Botta GA (2009) Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries 3: 295-299.
18. Mazzariol A, Roelofsen E, Koncan R, Voss A, Cornaglia G (2007) Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands. Antimicrob Agents Chemother 51: 1082-1884.
19. Miranda G, Castro N, Leanos B, Valenzuela A, Garza-Ramos U, Rojas T, Solórzano F, Chihu L, Silva J.(2004) Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum beta- lactamase in a Mexican pediatric hospital. J Clin Microbiol 42:30-35.
20. Labombardi VJ, Rojtman A, Tran K (2006) Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiellapneumoniae and Escherichia coli. Diagn Microbiol Infect Dis 56: 313-315.
21. Alcantar-Curiel D, Tinoco JC, Gayosso C, Carlos A, Daza C, Perez-Prado MC, Salcido L, Santos JI, Alpuche-Aranda CM.(2004) Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta-lactamase- producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 38:1067- 1074.
22. Avci IY, Kilic S, Acikel CH, Ucar M, Hasde M, Eyigun CP, Pahsa A, Cetiner S (2006) Outpatient prescription of oral antibiotics in a training hospital in Turkey: trends in the last decade. J Infect 52: 9-14.
23. Loh LC, Chin HK, Chong YY, Jeyaratnam A, Raman S, Vijayasingham P, Thayaparan T, Kumar S (2007) Klebsiella pneumoniae respiratory isolates from 2000 to 2004 in a Malaysian hospital: characteristics and relation to hospital antibiotics consumption. Singapore Med J 48: 813-818.
24. Paterson DL (2000) Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 6: 460-463.
25. Aktas Z, Bal C, Midilli K, Poirel L, Nordmann P (2006) First IMP-1-producing Klebsiella pneumoniae isolate in Turkey. Clin Microbiol Infect 12: 695-6.
26. Paterson DL, Bonomo RA (2005) Extended-spectrum β- lactamases: a Clinical Update. Clin Microbiol Rev 18: 657-686.